194 related articles for article (PubMed ID: 32994401)
1. Immune response and endocytosis pathways are associated with the resilience against Alzheimer's disease.
Tesi N; van der Lee SJ; Hulsman M; Jansen IE; Stringa N; van Schoor NM; Scheltens P; van der Flier WM; Huisman M; Reinders MJT; Holstege H
Transl Psychiatry; 2020 Sep; 10(1):332. PubMed ID: 32994401
[TBL] [Abstract][Full Text] [Related]
2. Cognitively healthy centenarians are genetically protected against Alzheimer's disease.
Tesi N; van der Lee S; Hulsman M; van Schoor NM; Huisman M; Pijnenburg Y; van der Flier WM; Reinders M; Holstege H
Alzheimers Dement; 2024 Jun; 20(6):3864-3875. PubMed ID: 38634500
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
[TBL] [Abstract][Full Text] [Related]
4. The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
Femminella GD; Harold D; Scott J; Williams J; Edison P;
J Alzheimers Dis; 2021; 79(1):127-139. PubMed ID: 33216025
[TBL] [Abstract][Full Text] [Related]
5. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
6. Pathway-specific polygenic risk scores correlate with clinical status and Alzheimer's-related biomarkers.
Schork NJ; Elman JA
Res Sq; 2023 Mar; ():. PubMed ID: 36909609
[No Abstract] [Full Text] [Related]
7. Genetically-regulated pathway-polygenic risk score (GRPa-PRS): A risk stratification method to identify genetically regulated pathways in polygenic diseases.
Li X; Fernandes BS; Liu A; Lu Y; Chen J; Zhao Z; Dai Y
medRxiv; 2023 Jun; ():. PubMed ID: 37425929
[TBL] [Abstract][Full Text] [Related]
8. Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers.
Schork NJ; Elman JA;
J Alzheimers Dis; 2023; 95(3):915-929. PubMed ID: 37661888
[TBL] [Abstract][Full Text] [Related]
9. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition.
Leonenko G; Shoai M; Bellou E; Sims R; Williams J; Hardy J; Escott-Price V;
Ann Neurol; 2019 Sep; 86(3):427-435. PubMed ID: 31199530
[TBL] [Abstract][Full Text] [Related]
10. From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.
Harrison JR; Mistry S; Muskett N; Escott-Price V
J Alzheimers Dis; 2020; 74(4):1271-1283. PubMed ID: 32250305
[TBL] [Abstract][Full Text] [Related]
11. Association of Alzheimer's disease polygenic risk scores with amyloid accumulation in cognitively intact older adults.
Luckett ES; Abakkouy Y; Reinartz M; Adamczuk K; Schaeverbeke J; Verstockt S; De Meyer S; Van Laere K; Dupont P; Cleynen I; Vandenberghe R
Alzheimers Res Ther; 2022 Sep; 14(1):138. PubMed ID: 36151568
[TBL] [Abstract][Full Text] [Related]
12. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds.
Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A
J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503
[TBL] [Abstract][Full Text] [Related]
13. Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.
Supiyev A; Karlsson R; Wang Y; Koch E; Hägg S; Kauppi K
Neurobiol Aging; 2023 Jun; 126():103-112. PubMed ID: 36965205
[TBL] [Abstract][Full Text] [Related]
14. Polygenic resilience score may be sensitive to preclinical Alzheimer's disease changes.
Eissman JM; Wells G; Khan OA; Liu D; Petyuk VA; Gifford KA; Dumitrescu L; Jefferson AL; Hohman TJ
Pac Symp Biocomput; 2023; 28():449-460. PubMed ID: 36540999
[TBL] [Abstract][Full Text] [Related]
15. Polygenic risk of Alzheimer's disease in the Faroe Islands.
Johansen M; Joensen S; Restorff M; Stórá T; Christy D; Gustavsson EK; Bian J; Guo Y; Farrer MJ; Petersen MS
Eur J Neurol; 2022 Aug; 29(8):2192-2200. PubMed ID: 35384166
[TBL] [Abstract][Full Text] [Related]
16. Probability of Alzheimer's disease based on common and rare genetic variants.
Escott-Price V; Schmidt KM
Alzheimers Res Ther; 2021 Aug; 13(1):140. PubMed ID: 34404470
[TBL] [Abstract][Full Text] [Related]
17. Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years.
Stocker H; Perna L; Weigl K; Möllers T; Schöttker B; Thomsen H; Holleczek B; Rujescu D; Brenner H
Mol Psychiatry; 2021 Oct; 26(10):5812-5822. PubMed ID: 32404947
[TBL] [Abstract][Full Text] [Related]
18. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
[TBL] [Abstract][Full Text] [Related]
19. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
20. Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease.
Ramanan VK; Heckman MG; Lesnick TG; Przybelski SA; Cahn EJ; Kosel ML; Murray ME; Mielke MM; Botha H; Graff-Radford J; Jones DT; Lowe VJ; Machulda MM; Jack CR; Knopman DS; Petersen RC; Ross OA; Vemuri P
Acta Neuropathol; 2022 May; 143(5):571-583. PubMed ID: 35412102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
